Servier and Google Cloud Extend Partnership to Accelerate AI-Powered Drug Development

Extended Partnership:
Servier and Google Cloud have extended their partnership for an additional five years, focusing on using AI and generative AI to accelerate drug development and improve R&D efficiency145.

AI Applications:
The partnership aims to leverage AI across various stages of drug development, including early research, clinical trials, production, and distribution, to reduce the average 15-year drug development timeline14.

Digital Transformation:
Servier views AI as crucial for its digital transformation, aiming to become a best-in-class digital player in the pharmaceutical sector13.

Generative AI Use Cases:
Approximately 60 gen AI use cases have been identified to accelerate drug development, including identifying new therapeutic targets, optimizing drug formulas, and digitalizing clinical trials1.

Data Security:
Google Cloud will support Servier in integrating AI technologies while ensuring data security and confidentiality, complying with strict regulations such as GDPR13.

Training and Tools:
Servier will provide its employees with tools based on Google and Google Cloud generative AI technologies, including Gemini large language models, to improve overall efficiency1.

Strategic Focus:
The partnership focuses on harnessing data and AI to increase innovation capabilities, serve patient needs, and address challenges in drug development134.

Sources:

1. https://www.prnewswire.com/news-releases/servier-and-google-cloud-expand-partnership-on-using-data-and-ai-302352283.html

3. https://servier.com/en/newsroom/servier-is-boosting-its-digital-transformation-with-google-cloud/

4. https://www.biopharmatrend.com/post/1120-servier-google-cloud-extend-partnership-to-accelerate-drug-development-with-ai/

5. https://www.newkerala.com/news/o/servier-google-cloud-strengthen-partnership-revolutionize-drug-development-ai-123